Vimarsana
Biggest News Aggregation in the World

Page 15 - Competitive Positioning News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Competitive Positioning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Competitive Positioning Today - Breaking & Trending Today

Population Health Management Market Set to Register a CAGR of 20.1% and Reach US$ 131.52 Billion by 2030 – Growth Plus Reports | - Vimarsana News

Population Health Management Market Set to Register a CAGR of 20.1% and Reach US$ 131.52 Billion by 2030 – Growth Plus Reports |

Published: March 29, 2023

A recent report by Growth Plus Reports estimated the global Population Health Management Market to be worth US$ 25.3 billion in 2021. From 2022 to 2030,

Source: medgadget.com
Related Topics:
United StatesManan SethiAsia PacificKoninklijke PhilipsRoute Of Administration OralPopulation Health Management Market ScopeHealth Catalyst Inc Mckesson CorporationConifer Health SolutionsKantar GroupDeloitte Touche TohmatsuApplication PharmaceuticalsAllscripts Healthcare Solutions IncEphmra European Pharmaceutical Marketing Research AssociationBrochure Of Population Health Management MarketCotiviti IncCustomer Base AssessmentEmployer GroupCerner CorporationUnitedhealth GroupStrategic DevelopmentResearch Centers AcademicsGe HealthcareSurgical CentersPremium ResearchPopulation Health Management Market
Rise In Asthma Prevalence as a Result of Poor Air Quality Will Drive Asthma & COPD Drugs Market to US$ 51.30 Billion by 2030, Says Growth Plus Reports | - Vimarsana News

Rise In Asthma Prevalence as a Result of Poor Air Quality Will Drive Asthma & COPD Drugs Market to US$ 51.30 Billion by 2030, Says Growth Plus Reports |

Published: March 29, 2023

The latest report from Growth Plus Reports analyzes the production, applications, demand, major manufacturers, and SWOT analysis of the global asthma

Source: medgadget.com
Related Topics:
United StatesAsia PacificManan SethiBoehringer Ingelheim GmbCustomer Base AssessmentPremium ResearchGlenmark PharmaceuticalsEphmra European Pharmaceutical Marketing Research AssociationRoche LtdAbbott LaboratoriesAmgen IncMerck CoStrategic DevelopmentTeva Pharmaceuticals Industries LtdVectura Group PlcAurobindo PharmaGrowth Plus ReportsMarket SizeGlobal AnalysisStrategic DevelopmentsPlus ReportsDisease TypeDrug ClassDistribution ChannelType Segmentation
Digital Genome Market to Hit US$ 31.30 Billion By 2030, Due to Technological Advancements | Growth Plus Reports | - Vimarsana News

Digital Genome Market to Hit US$ 31.30 Billion By 2030, Due to Technological Advancements | Growth Plus Reports |

Published: March 29, 2023

The latest report from Growth Plus Reports analyzes the production, applications, demand, major manufacturers, and SWOT analysis of the global digital

Source: medgadget.com
Related Topics:
United StatesAsia PacificManan SethiPacific BiosciencePremium ResearchPerkinelmer IncStrategic DevelopmentCustomer Base AssessmentContract Research OrganizationsNanostring Technologies IncService Type IaaEphmra European Pharmaceutical Marketing Research AssociationRoche LtdIllumina IncGe Healthcare Genomic Health IncEnd User PharmaceuticalsResearch InstitutesRegeneron Pharmaceuticals IncResearch DevelopmentInscripta IncSolutions For Drug Discovery MarketVeritas Genetics IncAgilent Technologies IncGenmark Diagnostics IncAnalysis Software
Prescription Drugs Market Growth Accelerated by Expansion in Hospitality Sector, Projected to Reach US$ 2067.25 Billion by 2030: Growth Plus Reports Study | - Vimarsana News

Prescription Drugs Market Growth Accelerated by Expansion in Hospitality Sector, Projected to Reach US$ 2067.25 Billion by 2030: Growth Plus Reports Study |

Published: March 29, 2023

According to a new Growth Plus Reports research, the global prescription drugs market is expected to reach US$ 2067.25 billion by 2030, with a revenue

Source: medgadget.com
Related Topics:
United StatesBristol Myers SquibbManan SethiEli LillyAsia PacificPfizer IncContract DevelopmentEphmra European Pharmaceutical Marketing Research AssociationRoche LtdAbbvie IncContract Research OrganizationsCustomer Base AssessmentLupin Pharmaceuticals IncRoute Of Administration OralManufacturing OrganizationGlaxosmithkline PlcMerck CoTechnology Internal NeuromodulationBiopharmaceutical CompaniesJohnson Services IncPremium ResearchAstrazeneca PlcLupin LtdMarket By Service Contract Manufacturing OrganizationContract Research Organization
Generalized Anxiety Disorder Therapeutics Market to Register a Steady CAGR of 3.60% Between 2022 – 2030 | Growth Plus Reports | - Vimarsana News

Generalized Anxiety Disorder Therapeutics Market to Register a Steady CAGR of 3.60% Between 2022 – 2030 | Growth Plus Reports |

Published: March 29, 2023

The global generalized anxiety disorder therapeutics market, estimated at US$ 8,869.50 million in 2021, is projected to surpass US$ 12,193 million by

Source: medgadget.com
Related Topics:
United StatesAsia PacificEli LillyManan SethiPfizer IncAbbott Laboratories IncEphmra European Pharmaceutical Marketing Research AssociationSurgical CentersGenentech IncTechnology Halogen LightsPremium ResearchAbbvie IncMedicine IncCustomer Base AssessmentBrain HealthEnd User Specialty CentersRoute Of Administration OralVistagen Therapeutics IncStrategic DevelopmentMerck CoGrowth PlusGlobal AnalysisStrategic DevelopmentsPlus ReportsDrug Class